Background: The mechanisms that regulate maintenance of persistent T H 2 cells and potentiate allergic inflammation are not well understood. Objective: The function of serine protease inhibitor 2A (Spi2A) was studied in mouse T H 2 cells, and the serine protease inhibitor B3 (SERPINB3) and SERPINB4 genes were studied in T H 2 cells from patients with grass pollen allergy. Methods: Spi2A-deficient T H 2 cells were studied in in vitro culture or in vivo after challenge of Spi2A knockout mice with ovalbumin in alum. Expression of SERPINB3 and SERPINB4 mRNA was measured in in vitro-cultured T H 2 cells and in ex vivo CD27 2 CD4 1 cells and innate lymphoid cell (ILC) 2 from patients with grass pollen allergy by using quantitative PCR. SERPINB3 and SERPINB4 mRNA levels were knocked down in cultured CD27
Background: The mechanisms that regulate maintenance of persistent T H 2 cells and potentiate allergic inflammation are not well understood. Objective: The function of serine protease inhibitor 2A (Spi2A) was studied in mouse T H 2 cells, and the serine protease inhibitor B3 (SERPINB3) and SERPINB4 genes were studied in T H 2 cells from patients with grass pollen allergy. Methods: Spi2A-deficient T H 2 cells were studied in in vitro culture or in vivo after challenge of Spi2A knockout mice with ovalbumin in alum. Expression of SERPINB3 and SERPINB4 mRNA was measured in in vitro-cultured T H 2 cells and in ex vivo CD27 2 CD4 1 cells and innate lymphoid cell (ILC) 2 from patients with grass pollen allergy by using quantitative PCR. SERPINB3 and SERPINB4 mRNA levels were knocked down in cultured CD27
2 CD4 1 cells with small hairpin RNA. Results: There were lower levels of in vitro-polarized T H 2 cells from Spi2A knockout mice (P < .005) and in vivo after ovalbumin challenge (P < .05), higher levels of apoptosis (Annexin V positivity, P < .005), and less lung allergic inflammation (number of lung eosinophils, P < .005). In vitro-polarized T H 2 cells from patients with grass pollen allergy expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P < .05) compared with unpolarized CD4 T cells. CD27
2 CD4 1 from patients with grass pollen allergy expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P < .0005) compared with CD27
1 CD4 1 cells. ILC2 expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P < .0005) compared with ILC1. Knockdown of either SERPINB3 or SERPINB4 mRNA (both P < .005) levels resulted in decreased viability of CD27 2 CD4 Persistent T H 2 cells are the principal cell population responsible for the maintenance of chronic allergic inflammation and the rapid relapse of acute allergic inflammation on allergen re-exposure. [1] [2] [3] The mechanisms that regulate the maintenance of persistent T H 2 cells and potentiate allergic inflammation remain elusive. Strong candidates for these persistent T H 2 cells are circulating human CD4 1 T cells, which express the prostaglandin D 2 receptor (CRTH2) and have a phenotype of terminally differentiated central effector/memory T cells based on T H 2 cytokine production, gene expression profile, and the ability to respond to allergens. 4, 5 In mice the differentiation of effector T H 2 cells into persistent T H 2 cells (referred to as memory T H 2 cells) requires escape from apoptosis. 6, 7 Such persistent T H 2 cells retain the cytokine expression profile of the effector cell. [8] [9] [10] Compared with T H 1 and CD8 1 effector cells, T H 2 cells are relatively resistant to apoptosis and refractory to the classical TNF receptor family-induced, activation-induced cell death (AICD) pathway of apoptosis. 11 Release of executioner cathepsins, such as cathepsins B and L, from the lysosome triggers cell death in response to several stimuli in a variety of physiologic settings. [12] [13] [14] We identified serine protease inhibitor 2A (Spi2A) as a physiologic inhibitor of the lysosomal death pathway in mice. 15 Spi2A, which is encoded by the Serpina3g gene on mouse chromosome 12, 16 is unusual for a serine protease inhibitor (Serpin) in that it inhibits not only serine proteases but also cysteine cathepsins and resides in the cytosol and nucleus. In human subjects squamous cell carcinoma antigen (SCCA) 1 (SERPINB3), which belongs to the ovalbumin (OVA)-Serpin family, 17 inhibits both serine proteinases, such as chymotrypsin, and cysteine proteinases, such as cathepsin L, K, S, and papain, 18 whereas the closely related Serpin SCCA-2 (SERPINB4) is able to inhibit serine proteinases, such as cathepsin G and mast cell chymase. 19 Both Spi2A in mice 15, 20 and SCCA-1 [21] [22] [23] and SCCA-2 24, 25 in human subjects are potent inhibitors of apoptosis.
We now show in mice and human subjects that intracellular Serpins are required for the survival of disease-causing memory T H 2 cells. Spi2A was upregulated in T H 2 but not T H 1 effectors in response to T-cell receptor (TCR) stimulation and cytokines. Development of T H 2 cells after immunization with OVA was impaired in Spi2A knockout (KO) mice, as was the development of memory allergic inflammatory responses in the lung. Both SERPINB3 and SERPINB4 were expressed in human T H 2 cells after in vitro polarization and in memory T H 2 cells from patients with pollen allergy. Importantly, knockdown of either SERPINB3 or SERPINB4 resulted in a drastic impairment of memory T H 2 cell survival. We conclude that antiapoptotic Serpins are potential targets for ablation of disease-causing memory T H 2 cells.
METHODS Mice
Spi2A KO mice were on the C57BL/6 background. 26 Wild-type C57BL/6 mice were obtained from Charles River Laboratories (Bar Harbor, Me). All mice were maintained in accordance with UK Home Office regulations.
Human subjects
Participants with grass pollen-induced seasonal allergic rhinoconjunctivitis (n 5 8) provided blood samples and answered symptom questionnaires (Table I ). Blood samples were collected during the grass pollen season (May-July). The study was approved by the South West London REC3 Research Ethics Committee and the Research Office of the Royal Brompton and Harefield NHS Foundation Trust.
T H 1 and T H 2 polarization in vitro
Mice. By using the protocol from Boonstra et al, 27 spleen and lymph node cells were harvested from Spi2A KO and wild-type mice, positively sorted with magnetic beads (Miltenyi Biotech, Bergisch Gladbach, Germany) for CD4
1

CD62L
1 CD44 2 cells, and then seeded at 10 6 /mL in RPMI containing anti-CD3 (2 mg/mL) and anti-CD28 (5 mg/mL) mAbs. For T H 1 polarization, cells were cultured with neutralizing anti-IL-4 mAb (10 mg/ml) and rIL-12 (10 ng/mL) for 4 days. For T H 2 polarization, cells were cultured with neutralizing anti-IFN-g mAb (10 mg/mL) and rIL-4 (10 ng/mL) for 4 days. Fresh T H 2 polarization medium plus IL-2 (10 ng/mL) was added to these cultures every 48 hours. All reagents were from eBioscience (San Diego, Calif).
Human subjects. Heparinized venous blood was collected from patients with grass pollen-induced allergy and seasonal allergic rhinitis. Whole blood was diluted 1:1 with RPMI 1640 media (Invitrogen), layered on Histopaque-1077 (Sigma-Aldrich, St Louis, Mo) density gradient (density 5 1.077 g/L), and centrifuged for 25 minutes at 1136g at room temperature. The PBMC layer was collected, washed, and resuspended in RPMI 1640. Cell viability was greater than 95%, as determined by using trypan blue exclusion. Naive CD4 1 CD45RA 1 T cells were negatively selected and enriched by using the EasySep Human Na€ ıve CD4 1 T Cell Isolation Kit (STEMCELL Technologies, Vancouver, British Columbia, Canada), according to the manufacturer's instructions. The purity of fractionated cell populations determined by using fluorescence-activated cell sorting (FACS) analysis with phycoerythrin (PE)-conjugated anti-CD45RA (5H9; BD Biosciences, San Jose, Calif) was 99%. Purified CD4 1 CD45RA 1 cells (10 6 /mL) were cultured in RPMI 1640 (Life Technologies, Gaithersburg, Md) supplemented with 10% FCS, 2 mmol/L L-glutamine (Life Technologies), 100 U/mL penicillin (Life Technologies), and 100 mg/mL streptomycin (Life Technologies). Cells were stimulated with plate-bound anti-CD3 (1 mg/mL; clone OKT3) and anti-CD28 (2 mg/mL; 37407; R&D Systems, Abingdon, United Kingdom) and rIL-2 (50 U/mL; R&D Systems). rIL-12 (2.5 ng/mL; R&D Systems) and anti-IL-4 (5 mg/mL; clone MP4-25D2; BD PharMingen) were added to direct T H 1 differentiation. rIL-4 (12.5 ng/mL; NBS Biologicals, Cambridge, United Kingdom), anti-IFN-g (5 mg/mL; clone B-B1; Invitrogen, Paisley, United Kingdom), and anti-IL-10 (5 mg/mL; clone JES3-9D7; Invitrogen) were added for T H 2 differentiation.
After 4 days, the cells were expanded under the same conditions in the absence of anti-CD3 or anti-CD28. Cells were then restimulated every 7 days. When required, cells were activated with phorbol 12-myristate 13-acetate (PMA; 5 ng/mL; Sigma-Aldrich) and ionomycin (500 ng/mL; Merck Millipore, Hertfordshire, United Kingdom) for 4 hours. In addition, cell lysates were collected to investigate gene expression by using RT-PCR, and cell supernatants were analyzed for cytokines and chemokines by using a human cytokine/chemokine magnetic bead panel 96-well plate assay (Milliplex Map Kit; Millipore, Danvers, Mass) and a Luminex xMAP Magpix platform (Merck Millipore), according to the manufacturer's instructions. 
Flow cytometry
For extracellular staining, the following mAbs were used: anti-CD4-allophycocyanin (APC)-Cy7 (BioLegend, San Diego, Calif), anti-T1/ST2-fluorescein isothiocyanate (FITC; clone DJ8; MD Biosciences, Oakdale, Minn), and anti-CD27-APC (eBioscience). For intracellular staining (ICS) with anti-IL-4-PE-Cy7, anti-IFN-g-Pacific Blue, and IL-5-PE (eBioscience), fixation and permeabilization were carried out according to the manufacturer's protocol (Cytofix/Cytoperm; BD Biosciences). Spleen cell suspensions were generated by means of mechanical disaggregation of whole spleens in RPMI with 10% FBS and then filtered through gauze to remove particular matter. Splenocytes (10 6 /mL) were stimulated with PMA (50 ng/mL), ionomycin (1 mg/mL; Sigma-Aldrich), and brefeldin A (10 mg/mL; eBioscience) for 5 hours and then stained with I-A b tetramer (APC) containing the OVA peptide 323-339 (OVA-tet), anti-CD4-APCCy7, and anti-T1/ST2-FITC in RPMI with 10% FBS for 1 hour at 378C with 7-actinomycin D to identify dead cells. 28 Cells were stained with OVA-tet (AAHAEINEA; National Institutes of Health Tetramer Facility, Atlanta, Ga) or negative control CLIP peptide/I-A b tetramer. Cells were then subjected to ICS. Apoptosis was measured by using Annexin V staining or intracellular anti-active caspase-3, according to the manufacturer's protocol (BD Biosciences). CD4
1
T cells were immunostained with anti-human CD45RO-PE (clone UCHL1) and CD45RA-FITC (clone 5H9; BD Biosciences) to check enrichment of human CD4 1 CD45RA 1 naive T cells from isolated PBMCs on day zero. Each week, resting cells were stimulated with PMA and ionomycin for 1 hour and brefeldin A for 4 hours before surface immunostaining with antihuman CD4-peridinin-chlorophyll-protein complex (PerCP; clone L200) and intracellular immunostaining with anti-human IL-5-APC (clone TRFK), anti-human IL-13-PerCP-cy5.5 (clone JES-5AZ), anti-human GATA-3-PECy7 (clone L50823), anti-human IFN-g-PE Cy5.5 (clone B27), and anti-human T-bet V450 (clone 04-46) antibodies (BD Biosciences), according to the manufacturer's protocol (Cytofix-Cytoperm, BD Biosciences). (>90% purity) from PBMCs from 6 patients with grass pollen allergy by using the following cell-surface antibodies: CD127-PE-Cy5, CD45-AF700,
Cy5.5, CD161-APC, FcεRIa-FITC, and lineage cocktail (CD3, CD14, CD19, CD20, and CD56) (FITC; BioLegend). Cells were sorted directly into RLT buffer before gene expression analysis by using RT-PCR.
Analysis of Serpin gene expression
In vitro T H 1-or T H 2-polarized cultures were reseeded in fresh nonpolarizing medium for 1 day with culture media containing IL-2 alone (10 ng/mL) or with either IL-4 (10 ng/mL), IFN-g (10 ng/mL), anti-CD3 (5 mg/mL), anti-CD30 (50 mg/mL), anti-OX40 (50 mg/mL), or anti-CD30 (50 mg/mL) plus OX40 (50 mg/mL; eBioscience). Each condition was performed in duplicate.
Total RNA from each sample was obtained by using the RNeasy Plus Micro Kit (Qiagen, Manchester, United Kingdom) and QiaShredder spin columns, according to the manufacturer's instructions. Real-time PCR reactions were run with the SYBR Green PCR Master mix (Applied Biosystems, Foster City, Calif) on a 7900HT Fast Real-Time PCR System (Applied Biosystems). Primer sequences for Serpina3g (Spi2A gene) and b 2 -microglobulin were from Winkler et al. 30 Levels of Serpina3g mRNA are expressed as fold over b 2 -microglobulin control mRNA. 31 Primer sequences of human IL4, IL13, GATA3, and TBET were from Shamji et al. 32 Primer sequences for SERPINB3 (forward 59-AGC CGC GGT CTC GTG C-39 and reverse 59-GGC AGC TGC AGC TTC TG-39) and SERPINB4 (forward 59-AGC CAC GGT CTC TCA G-39 and reverse 59-GCA GCT GCA GCT TCC A-39) were from Mitsuishi et al. 33 The level of human mRNA was expressed as fold over EFA2 control mRNA. 32 Gene knockdown of SERPINB3 and SERPINB4
The following GIPZ lentiviruses were used (Thermo Fisher Scientific Biosciences GmbH, Paisley, United Kingdom): small hairpin RNA (shRNA) mir SERPINB3 or SERPINB4, nonsilencing GIPZ lentiviral shRNAmir, and GAPDH-GIPZ lentiviral shRNAmir positive control. In addition, nontransduced cells were used as controls. CD4
1
CD27
2 cells were transduced with lentivirus (multiplicity of infection 5 3) by means of centrifugation at 378C for 90 minutes in Polybrene (4 mg/mL), stimulated with anti-CD3 (0.5 mg/mL) and anti-CD28 (0.5 mg/mL) for 4 days, and then analyzed by using flow cytometry for CD4 and green fluorescent protein expression. The viability of CD27 2 CD4 1 T cells was assessed by using trypan blue exclusion. of total splenocytes (6SEM, n 5 6-8). *P < .05, **P < .005, and ***P < .0005. ns, P > .05 (not significant). Broken horizontal lines show the limit of detection.
OVA-alum T H 2 model
Naive Spi2A KO and wild-type mice were immunized (sensitization) by means of intraperitoneal injection of OVA (100 mg; Grade V; SigmaAldrich) and alum (4 mg; Pierce, Rockford, Ill) on days 0 and 5. Mice were subjected to 3 daily intranasal challenges with OVA in PBS (0.5% wt/vol) at various time points after sensitization to induce airway inflammation (sensitization-challenge [S-C]). In addition, some mice underwent intranasal challenge alone. For both S-C and challenge mice, analysis was made 1 day after the last intranasal challenge. For bronchoalveolar lavage (BAL) fluid extraction, the lungs of mice were perfused 5 times with lidocaine chloride in PBS (0.4% wt/vol; SigmaAldrich) and centrifuged at 400g to obtain BAL fluid cells and supernatants. Cells (about 300 cells per mouse) underwent the cytospin process and were stained with modified Giemsa staining (Sigma-Aldrich) to enumerate numbers of infiltrating eosinophils and lymphocytes. To measure the sensitization index (SI) for the lung, T H 2 response was calculated as follows: SI 5 ðResponse in S -C miceÞ2ðResponse in challenge miceÞ: ELISA Serum IgE concentrations were measured, as previously described. 34 Concentrations of IL-4 and IFN-g were measured with Luminex technology (Invitrogen/Millipore/Luminex, Waltham, Mass). Detection levels for IL-4 and IFN-g were 3.1 and 2.3 ng/mL, respectively.
Statistical analysis
Significance values were calculated by using 2-way ANOVA with the Bonferroni posttest or 2-tailed t test (Prism software; GraphPad Software, La Jolla, Calif).
RESULTS
Spi2A is required for development of mouse T H 2 cells
We examined the role of the cathepsin-specific Serpin Spi2A in cell death of polarized T H 2 cells in vitro. We used a non-antigen- were then challenged (S-C mice) after a certain period of time (dS) with intranasal (i.n.) injection of OVA once per day on 3 consecutive days (dS, dS11, and dS12). Analysis was performed on naive mice (N) or challenge-only mice (C) 1 day after the last intranasal challenge (dS13). B, Histograms of mean 6 SEM (n 5 6-8) eosinophil and lymphocyte numbers in BAL fluid and concentration of IL-4 and OVA-IgE in the sera in experimental groups of mice. S-C mice were challenged 10 days after sensitization. C, Line graphs of allergic memory index for BAL fluid eosinophils or lymphocytes and serum IL-4 or OVA-IgE levels versus time before challenge after sensitization. Memory Index 5 (Response in S-C mice) 2 (Response in challenge mice). *P < .05, **P < .005, and ***P < .0005, ns, P > .05 (not significant).
based system in which naive CD4 T cells (CD4 1 CD62L 1 ) were magnetic bead sorted from wild-type C57BL6 mice and then stimulated through the TCR and CD28 after culture under appropriate polarizing conditions to generate T H 1 or T H 2 cells. 27 This was verified by using ICS and flow cytometry to detect signature cytokines (Fig 1, A) . We determined whether Spi2A mRNA was upregulated in T H 1 or T H 2 cells. Stimulation through the TCR with anti-CD3 antibody induced expression of Spi2A mRNA in T H 2 cells (5-fold greater than the naive level) but not T H 1 cells (Fig 1, B) . Furthermore, stimulation of the IFN-g receptor did not induce Spi2A expression in T H 1 cells, whereas stimulation through the IL-4 receptor resulted in Spi2A mRNA upregulation in T H 2 cells (2-fold greater than the naive level; Fig 1, B) . Costimulation through both CD30 and OX40 (CD134) TNF receptor (Fig 4, J) , GATA3 (Fig  4, K) , T-bet (Fig 4, L) , SERPINB3 (Fig 4, M) , and SERPINB4 (Fig 4, N) mRNA in ILC2s relative to ILC1s. **P < .005 and ***P < .0005.
family members also failed to induce Spi2A mRNA in either T H 1 or T H 2 cells (Fig 1, B) . We conclude that TCR and cytokine stimulation results in Spi2A upregulation in T H 2 but not T H 1 cells.
To examine the requirements for Spi2A in CD4 T-cell differentiation, we measured numbers of T H 1 (IFN-g (Fig 1, A) . However, when the cultures were polarized for T H 2 development and then rested until day 8, we observed a 9-fold decrease (P 5 .0023) in the percentage of T H 2 cells (IFN-g ) from Spi2A KO mice compared with those from wild-type mice (Fig 1, C) and a corresponding decrease in IL-4 secretion (see Fig E1 in this article' s Online Repository at www.jacionline.org). As an additional differentiation marker, we examined expression of the IL-1 receptor family member ST2, which is expressed on persistently activated T H 2 cells. 35 We observed a significant decrease in the percentage of ST2 
CD4
1 cells (P 5 .0027) in cultures from Spi2A KO compared with wild-type mice (Fig 1, D) . The specific requirement of T H 2 cells for Spi2A was presumably due to upregulation through TCR and IL-4 stimulation, whereas T H 1 cells did not upregulate Spi2A and therefore were not affected in Spi2A KO mice.
Spi2A KO T H 2 cells are susceptible to apoptosis
We examined the mechanism through which Spi2A facilitated differentiation of T H 2 cells in vitro. We determined whether Spi2A was required for either activation or proliferation of T H 2 We then examined the susceptibility of T H 2 cells to apoptosis. ICS for activated caspase-3 in the cytoplasm (Fig 1, E) or phosphatidylserine expression on the plasma membrane with Annexin V (Fig 1, F) revealed that T H 1 cells underwent higher levels of apoptosis compared with T H 2 cells. This is consistent with earlier reports of the refractory nature of T H 2 cells to classic AICD. 11 However, we observed that Spi2A KO T H 1 cells were no more susceptible to apoptosis than wild-type T H 1 cells. In contrast, we observed a significant increase in the percentage of activated caspase-3-positive (P 5 .0032; Fig 1, E) and Annexin V-positive (P 5 .0071; Fig 1, F) Spi2A KO T H 2 cells compared with wild-type cells. We conclude that Spi2A is required for in vitro differentiation of T H 2 cells by ensuring survival through suppression of apoptosis.
Diminished numbers of T H 2 cells after challenge of Spi2A KO mice
We determined whether Spi2A controlled the level of T H 2 cell development in vivo. Mice were immunized on days 0 and 5 (Fig 2, A) , and numbers of OVA-specific CD4 T cells were measured in the spleen by staining with I-A b tetramers refolded with OVA peptide (amino acid sequence 323-339 [OVA-tet]), followed by flow cytometry (Fig 2, B , and see Fig E4 in this article's Online Repository at www.jacionline.org). 36, 37 Within the population of OVA-tet 1 CD4 1 cells, we measured numbers of phenotypically T H 2 cells based on the effector phenotype of either intracellular IL-4 or IL-5 production (Fig 2, C) . In addition, we also used expression of the ST2 differentiation marker 38 for T H 2 cells, which is important because CD4 T cells that are negative for T H 1 or T H 2 cytokine production can also form long-lived T H 2 effector cells. 7 The representative flow cytometric experiment in Fig 2, C, 
CD4
1 cells increased to a maximal level on day 20 and then decreased steadily to a residual memory level at day 60 (Fig 2, D) 
1 : P 5 .0003). We conclude that Spi2A determines the numbers of T H 2 effector and memory cells throughout the T H 2 response to OVA in vivo.
Diminished inflammatory allergic responses in Spi2A KO mice
To determine the physiologic relevance of Spi2A in T H 2 cell survival, we examined allergic inflammation in the lungs of Spi2A KO mice after OVA challenge. Wild-type mice were sensitized by means of intraperitoneal injection with OVA in alum to generate T H 2 cells as before (Fig 2) , challenged after various lengths of time with repeated intranasal injection of OVA in PBS (S-C mice), 39 and then analyzed 1 day later (Fig 3,  A and B) . We observed a robust T H 2-mediated inflammatory response in the lungs of S-C mice, as evidenced by the recovery of eosinophils and lymphocytes from BAL fluid (Fig 3, B) . The lung inflammatory response was dependent on sensitization because the level of eosinophil and lymphocyte influx in challenge-only mice was significantly less than in S-C mice (Fig 3, B) . OVA-specific IgE levels were significantly greater in the S-C group compared with the challenge group because they were sensitized twice by means of intraperitoneal injection and had more time to develop a B-cell response. This response is a T H 2 response because of the presence of the adjuvant alum, which promotes T H 2 skewing of the immune response (Fig 3, B) . The difference in allergic inflammation response (as indicated by either numbers of BAL eosinophils or lymphocytes or concentration of serum IL-4 or OVA-IgE) in S-C mice compared with challenge-only mice was calculated and used as an indication of the relative magnitude of the allergic response to OVA (allergic index). In contrast, we did not observe any decrease in T H 1 responses in Spi2A KO mice, as evidenced by serum levels of IFN-g or anti-OVA IgG 2a (see Fig E5 in this article' s Online Repository at www.jacionline.org).
We examined T H 2-driven inflammatory lung responses in Spi2A KO mice. There was a significant decrease in allergic memory indices in BAL fluid (number of eosinophils, P 5 .003; number of lymphocytes, P 0.03) and serum (IL-4 concentration, P 5 .002; OVA-IgE concentration, P 5 .004) in Spi2A KO mice compared with those in wild-type mice on day 20 after immunization (Fig 3, C) . The deficit in the allergic memory with lentiviruses. *P < .05, **P < .005, and ***P < .0005.
=
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 2 response also extended to 40 days after immunization. Taken together, we conclude that the defect in T H 2 memory development in Spi2A KO mice results in decreased allergic inflammatory responses in the lung.
SERPINB3 and SERPINB4 are upregulated in human T H 2 cells
Human subjects lack a homologue of mouse Serpina3g, which encodes Spi2A, but express the OVA Serpins SCCA-1 and SCCA-2, which, like Spi2A, are inhibitors of apoptotic cysteine cathepsins.
14,16 Therefore we determined whether SCCA-1 and SCCA-2 have an equivalent role in human T H 2 cells to Spi2A in mouse T H 2 cells. We examined the development of T H 2 cells from allergic patients (Table I) after culture under T H 2 cell polarization conditions. 40 After 3 weeks of culture, we observed the development of T H 2 cells, as evidenced by increased intracellular expression of IL-4, compared with nonpolarized CD4 T cells (Fig 4, A) . Over the course of 4 weeks, we observed sustained and significant increases in expression of the genes encoding the T H 2 cytokines IL-4 (P 5 .0002; Fig 4, B) , IL-5 (P 5 .0002; Fig 4, C) , and the GATA-3 transcription factor (P 5 .0002; Fig 4, C) compared with CD4 T cells cultured under nonpolarizing conditions. Culture under T H 2-polarizing conditions resulted in the corresponding downregulation of the T H 1-specific T-bet gene expression compared with CD4 T cells cultured under nonpolarizing conditions (P 5 .002; Fig 4, E) . We observed the sustained and significant upregulation of SERPINB3 (P 5 .006; Fig 4, F) and SERPINB4 (P 5 .006; Fig 4, G) compared with expression in unpolarized cells from as early as week 1 of polarization. Comparison of the expression of SERPINB3 (r 5 0.54, P 5 .0014) and SERPINB4 (r 5 0.71, P < .0001) with that of the T H 2 master transcription factor GATA-3 revealed the significant correlation of both Serpin genes with GATA3 expression (Fig 4, H) . We conclude that the genes encoding the antiapoptotic OVA Serpins SCCA-1 and SCCA-2 are upregulated in human T H 2 cells.
Innate lymphoid cell 2 (ILC2) has been implicated in lung inflammation through production of T H 2 cytokines, whereas innate lymphoid cell 1 (ILC1) has been implicated in the production of T H 1 cytokines. 41 ILC1 and ILC2 were FACS purified from the blood of patients with pollen allergy (Fig 4, I) . Numbers of ILC2 from these patients were greater than those of ILC1s (P < .01). ILC2 counts were confirmed by upregulation of IL5 (Fig 4, J) and GATA3 (Fig 4, K) mRNA compared with that in ILC1s (both P 5 .002), and ILC1 counts were confirmed by upregulation of T-bet mRNA compared with that in ILC2 (P 5 .002; Fig 4, L) . Ex vivo ILC2s expressed about 9 times more SERPINB3 (Fig 4, M) and SERPINB4 (Fig 4, M) mRNA than ILC1 (both P 5 .002). This implies a role for SCAA-1 and SCCA-2 in ILC2, as well as T H 2 cells, in patients with pollen-induced allergic responses.
The surface molecule CRTH2 is a marker of human memory T H 2 cells, 5 and expression of CRTH2 (prostaglandin D 2 receptor 2, CCR4, and CCR7) and T H 2 cytokines is associated specifically with pathogenic terminally differentiated CD27
2
CD4
1 memory cells in allergic patients. 4 Flow cytometry on ex vivo CD4 T cells from patients with grass pollen allergy (Fig 5, A) revealed that the CD27
2
CD4
1 population contained significantly greater levels (P 5 .002) of CRTH2 (Fig 5, B) . The T H 2 phenotype of CD27 2 CD4 1 cells from allergic patients was confirmed by significantly increased expression of the genes encoding IL-4, IL-5, and IL-13 (all P 5.0002) compared with CD27
1
CD4
1 cells after 18 hours of in vitro stimulation with anti-CD3 antibody (Fig 5, C) . We observed significant upregulation of both SERPINB3 (P 5 .0002) and SERPINB4 (P 5 .0002) expression in this memory T H 2 cell population (CD27 2 CD4 1 ) compared with that in a non-T H 2 cell population (CD27 1 CD4 1 ) from allergic patients (Fig 5, D) . The T H 2 phenotype of CD4
1
CD27
2 cells was also confirmed by significantly increased secretion of the T H 2 signature cytokines IL-4, IL-5, IL-9, and IL-13 (all P 5 .0002; Fig 5, E) and the T H 2 signature chemokines human macrophage-derived chemokine (P 5 .007), CXCL8 (P 5 .0002), and RANTES (CCL5; P 5 .01; Fig 5, F 1 CD4 1 population was confirmed by the increased expression of IFNG (Fig 5, C) and T-bet (Fig 5, D) mRNA and secretion of IFN-g (Fig 5, E) compared with that in CD27
2 CD4 1 cells (all P < .0005). Therefore in our patient group CD27
2
CD4
1 cells are significantly enriched for memory T H 2 cells. These data indicate that both genes encoding the SCCA-1 and SCCA-2 OVA Serpins are specifically upregulated in allergy-associated memory T H 2 cells from human patients.
SERPINB3 and SERPINB4 promote the viability of human allergic T H 2 cells
We next determined the functional significance of SERPINB3 and SERPINB4 upregulation in T H 2 cells from patients with grass pollen allergy. We purified CD4 T cells from allergic patients and then transduced them with lentivirus encoding control or shRNA specific for either SERPINB3 or SERPINB4. Transduced cells were identified based on expression of green fluorescent protein (Fig 6, A) , which was encoded on a bicistronic message with shRNA. At least 85% of total cells were transduced with either control or SERPINB3 and SERPINB4 shRNAs (Fig 6, B) . We observed an about 80% knockdown in both SERPINB3 and SERPINB4 messages after transduction with shRNA (Fig 6, C) .
We next cultured transduced CD4 T cells with anti-CD3/IL-2, and after about 6 days, we observed a significant and sustained decrease in the number of viable CD27
2
CD4
1 cells transduced with either SERPINB3 and SERPINB4 shRNA compared with cells transduced with control shRNA (Fig 6, E) . The impaired viability persisted for up to 12 days, at which point controltransduced CD27
2
CD4
1 cells retained greater than 80% viability, whereas cells lacking SERPINB3 or SERPINB4 expression were less than 30% viable (Fig 6, E and F) . The reduced viability also resulted in a decrease in IL-4 and IL-13 production (Fig 6, E and F) . We conclude that ablation of either SERPINB3 or SERPINB4 gene expression decreases the viability of clinically relevant T H 2 memory cells.
DISCUSSION
We show that the chymotrypsin-like Serpin Spi2A facilitated the survival of T H 2 effectors in vivo and that ablation of Spi2A resulted in alleviation of allergic inflammatory responses in the lung. We also demonstrate that the OVA Serpins SCAA-1 and SCAA-2 protect allergic memory T H 2 cells from death in patients with grass pollen-induced allergic rhinitis. Therefore, despite being members of different Serpin families, Spi2A and SCAA-1/ SCAA-2 are functionally equivalent in their ability to ensure the survival of memory T H 2 cells in both mice and human subjects.
The antiapoptotic activities of SCAA-1, 21-23 SCAA-2, 24,25 and Spi2A 15, 20 are well known and mediated by inhibition of cathepsins B and L in cytoplasm. In the present study we show that the cytoprotection afforded by SCAA-1/SCAA-2 and Spi2A extends to human and mouse T H 2 cells. There are important differences between the roles Spi2A plays in T H 2 cells compared with other T cells. We found no evidence for a role for Spi2A in T H 1 cell survival. However, use of a more physiologically relevant model for in vivo T H 1 development than OVA plus alum immunization would be useful to explore this possibility more fully. Spi2A is a physiologic target of the nuclear factor kB transcription factor 15, 42 and a target of signal transducer and activator of transcription (STAT) transcription 43 induced by cytokines (eg, IL-15 31 and IL-7 44 ) and growth factors (eg, erythropoietin). 26 Therefore the differential effect of TCR signals that upregulate Spi2A in T H 2 cells but not T H 1 cells might be due to the additive effects of IL-4 through STAT6 and the lack of an effect by IFN-g through STAT3. However, Spi2A can be induced by IFN-g in activated macrophages, 43 and therefore it is possible that in different physiologic settings IFN-g can affect T H 1 cell survival through Spi2A upregulation. SCCA-1/SCCA-2 expression has been noted previously in human mononuclear cells, 45 and intriguingly, it has been reported that deficiency in mouse Serpinb3a, which is thought to be the homologue of human SCAA-1/SCAA-2, reduces airway hyperresponsiveness by limiting goblet cell hyperplasia. 46 In contrast to our findings with OVA-specific IgE levels in our Serpina3g (Spi2A) KO mice, levels of HDM-specific IgG 1 and IgE were no different between Serpinb3a KO and wild-type mice. 46 The mouse strain (C57Bl/6 vs BALB/c), allergen (HDM vs OVA), and especially route of sensitization (lung vs intraperitoneal) might explain the discrepancy. Therefore it will be important when evaluating the physiologic relevance of SERPINB3 and SERPINB4 in humanized mice to use a variety of allergenic models.
A major question for the development of T H 2 memory is the following: How do T H 2 memory cells and their precursors escape apoptosis? In vitro polarization studies have concluded that compared with T H 1 effectors, T H 2 cells are relatively resistant to classical AICD. 11 Our in vitro polarization study also shows higher levels of apoptosis in T H 1 cells than in T H 2 cells. However, the differences in apoptosis observed for T H 1 and T H 2 cells might also be affected by differences in the culture conditions used to generate each population. Despite this caveat, our results show clearly that Spi2A protects T H 2 but not T H 1 cells from apoptosis and therefore point to the lysosomal pathway of cell death controlling T H 2 cell survival. Spi2A deficiency reduced T H 2 cell numbers in vivo but did not affect IL-13 production in our lung inflammation model. Although SERPINB3 and SERPINB4 mRNA is expressed in human ILC2, we do not know whether Spi2A is expressed in mouse ILC2. Further studies will clarify whether Spi2A, SCAA-1, and SCAA-2 control the survival of other producers of allergic cytokines (eg, ILC2) in patients with lung inflammatory disease.
Factors affecting the initiation and course of allergic inflammation act in a narrow window in early life or even perinatally. 47 The refractory nature of allergic disease to cytokine therapy, which seeks to shift the T H 2 balance to T H 1, can be explained in terms of the stability of T H 2 memory cells that develop very early in life. 48 Therefore it would be advantageous to be able to eliminate the persistent T H 2 memory cells that give rise to atopic [49] [50] [51] and allergic diseases, such as asthma, 52 through induction of apoptosis. 49, 50, [52] [53] [54] We show that the targeting of SERPINB3 and SERPINB4 messages by shRNA drastically impaired the viability of memory T H 2 cells in patients with grass pollen allergy. Furthermore, expression of SERPINB3 and SERPINB4 in ILC2s implies that mRNA knockdown can also ablate allergenic innate immune system cells. Alleviation of allergic asthma by means of in vivo GATA3 mRNA knockdown in T H 2 cells provides support for the concept of targeting memory and effector T H 2 cells by using SERPINB3 and SERPINB4 mRNA knockdown. 55 It remains to be determined whether SERPINB3 and SERPINB4 also control memory CD8 T-cell responses in human subjects, as is the case for Spi2A in mice. 31, 44 A localized therapeutic approach targeting memory T H 2 cells would potentially deplete the reservoir of allergic disease and therefore complement antiallergic drugs and cytokine therapy. Effect of Spi2A deficiency on serum markers after OVA plus alum immunization. Wild-type C57BL/6 mice and Spi2A KO mice were subjected to sensitization and challenge with OVA, as described in Fig 3, A. At various time points, serum levels of immunologic indicators were determined, and sensitization indices were calculated. Mean 6 SEM sensitization indices are shown (n 5 6 cultures). *P < .05 and **P < .05. N.S., Not significant.
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